scholarly journals INFLUENCE OF THE DEXTRAN 70 ON AGGREGATION ANTITUMOR CYTOKINE EMAP II

2019 ◽  
Vol 0 (3(47)) ◽  
pp. 6-18
Author(s):  
Л. А. Коломієць ◽  
Д. М. Ложко ◽  
В. М. Заєць ◽  
О. Ю. Чуніхін ◽  
Н. В. Гордовська ◽  
...  
Keyword(s):  
2020 ◽  
Vol 72 (1) ◽  
pp. 238-245 ◽  
Author(s):  
L. A. Kolomiiets ◽  
N. V. Vorobyova ◽  
D. M. Lozhko ◽  
V. M. Zayets ◽  
A. I. Kornelyuk

1980 ◽  
Vol 43 (01) ◽  
pp. 034-037 ◽  
Author(s):  
Michael J Metcalf

SummaryThe susceptibility to lysis of artificial thrombi formed from native rabbit blood in the presence or absence of dextran was determined using the Chandler loop technique. Thrombi of identical weight were formed in the presence of saline or dextran and when spontaneous thrombolysis was allowed to take place, thrombi formed in the presence of dextran 70 were lysed to a greater extent than those formed under control conditions.The possible factors influencing this observation were studied. Increasing concentrations of streptokinase increased the extent of thrombolysis in both control and dextran treated thrombi. Maximal streptokinase induced thrombolysis occurred in the presence of a 2 per cent final concentration of dextran Mw 40,000 and 500,000 and dextran 70 at a final concentration of 1.2 per cent.Increased thrombolysis was not observed when albumin was substituted for dextran.Finally, similar observations were recorded for streptokinase induced thrombolysis using human blood.


2009 ◽  
Vol 17 (5) ◽  
pp. 1442-1452 ◽  
Author(s):  
Roderich E. Schwarz ◽  
Niranjan Awasthi ◽  
Srivani Konduri ◽  
Danielle Cafasso ◽  
Margaret A. Schwarz

1998 ◽  
Vol 42 (8) ◽  
pp. 982-986 ◽  
Author(s):  
I. Power ◽  
D. W. Noble ◽  
A. Winter ◽  
I. A. Greer
Keyword(s):  

1985 ◽  
Vol 43 (3) ◽  
pp. 479-480 ◽  
Author(s):  
Edward A. Zbella ◽  
Jacob Moise ◽  
Sandra A. Carson
Keyword(s):  

1975 ◽  
Vol 13 (11) ◽  
pp. 41-43

Two preparations of dextran have been tried for prevention of venous thromboembolic disease, dextran-40 (average m. w. 40,000) and dextran-70 (average m.w. 70,000). Dextrans reduce platelet aggregation and lower blood viscosity.1 Dextran may also reduce the peri-operative rise in the coagulation factors V and VIII.2 However, in some tests dextrans increase platelet aggregation3 and accelerate fibrin formation,4 so that only clinical trial can show whether dextran reduces the incidence of either deep-vein thrombosis or of pulmonary embolism.


2003 ◽  
Vol 44 (5) ◽  
pp. 1801 ◽  
Author(s):  
Ruud Clarijs ◽  
Lia Schalkwijk ◽  
Dirk J. Ruiter ◽  
Robert M. W. de Waal

Sign in / Sign up

Export Citation Format

Share Document